# A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses

> **Newsylist Open Intelligence Dossier** · First detected: 2026-07-17 03:29 UTC · Category: Health · Sources: 10 · Current Velocity: 9.49

## Executive Summary
10 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

## Intelligence Brief
"A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses" is generating significant coverage in the Health category, with 12 articles from 10 distinct sources tracked by Newsylist so far.


Outlets currently covering the story include BioPharm International, Oncodaily, Inside Precision Medicine and WDBJ7. Newsylist measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### Why is "A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Eli" trending?
Because 10 independent news sources published 12 articles about it in a short window — a coverage burst Newsylist classifies as a trend.

### How does Newsylist measure this trend?
Newsylist scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.

### Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.

## Key People, Organizations & Locations
People, Experimental, Vaccine, Developing, Anirban, Prevent Pancreatic Cancer, KRAS-Targeting Vaccine, Sandra Misale Intercepting PDAC, Pancreatic Cancer Prevention Trial, Johns Hopkins-Developed KRAS Vaccine Shows Durable Immune Response

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| BioPharm International | Johns Hopkins-Developed KRAS Vaccine Shows Durable Immune Response in Pancreatic Cancer Prevention Trial | 2026-07-16 05:01 | [Source Link](https://news.google.com/rss/articles/CBMi4AFBVV95cUxOc0tSMXRTdHNES1ktSktvX2tjcG55ZUtlbXpqZmY2R0FnZHFQU05wSnQ2TnFKLUJ4TTI5SHZuVlpFbkRXQ3BuMGd1bWoydFBwYlljYlRITUcwSzdhLTJrOGU3WHZKeFlnZW9XY2V4aEp6RUpta2ZGUVNZWVA0eFMzRGdNTlM2cVJZb3JQbVBvOTBDemVCTnRKV3h2YUQ2VXFkdTZoc2xJZmIxNFVrRDQybkY3NFFVcHRyVXhDRXZBT1ZtT251dWRxT2tjOVVMS0dQVXV3VFpRcW5vN3JzWFlKXw?oc=5) |
| Oncodaily | Sandra Misale: Intercepting PDAC in High-risk Individuals by KRAS-Targeting Vaccine | 2026-07-16 05:01 | [Source Link](https://news.google.com/rss/articles/CBMiX0FVX3lxTE5FVUVIY3pyZDZIMF9BZ05UbjRhLWZfVHNDWnBycS1VRVkzZ0dqeS14RUUzYjFmV3JQdEI1UWQyWE1pTWdQY29xZjBaQ1hwb0w3MklHY29UeU40TWR1UVNj?oc=5) |
| Inside Precision Medicine | Pancreatic Cancer Vaccine Triggers Immune Response Before Tumors Develop | 2026-07-16 05:01 | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxQZk1OZ0RWNGIzdDNudC1mVHJoaXJNa3hTdzJpMzVEYWs0ZnZXVE9CUFRlUVZlZTItenlhdjlCN29kTG5aQVVRSzI5eXVHdndYaUM2dkdxZlgxWDgxUlZrbGp6NFI1cmNQTE84SlB4Smx5YXdrWE9DUkk3aGNtZ3BxY3N1V3JFd2Vqa0J3cU5lVk14UTZsakxtTnF0emxZOEhqZ3ppX1cxQlI4enMtZ3pnZ205QUlDMjE3Tl9WS0I3RkZqRnFxeW9MRg?oc=5) |
| WDBJ7 | HOMETOWN HEALTH: New vaccine could prevent pancreatic cancer in high risk patients | 2026-07-16 05:01 | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxNS1pEVUlvU0twbHNXb1dJTlZXNmt2QUZlTXliSGM4MkJ3MEg5M1lKUjVsaUZVMjFaTXZOS0FYdGdHNV83T0JaTkQ2NlQ2ODJkTmxWSW9zN3BzV2R4VFVFdzk3MWhrSU5iMVJaOHNSd01yUmpFV0xvWERJdlhEUXU0a3ZmdWtkTU5NbUZPaWtRUXRNNThTUk1Xbml1ek1faHg5VHNWN0g2eXplVllTd2NjZlZ30gHGAUFVX3lxTE1JdksxYzcwSENwWnpDdGlyZE5ON0pVMnRyMzNPOGRHSnJBWUhYazYwSWtPVG9TQW1ZMVBUZzI4YjMyV3ZkeGs4d2ozREpFREpjeFFjUXh1UENURmlFWUIwZEkzVVNYYTZtdEJ6bjdFRV94THVZbXUxZzNRbG96Ry1QczdEWUxzYi1ZQVphemY2RU5lRXA1RGt4WFpRdzlMLUQ) |
| El Mundo America | Developing a Vaccine to Prevent Pancreatic Cancer in High-Risk Individuals | 2026-07-16 05:01 | [Source Link](https://news.google.com/rss/articles/CBMiiwFBVV95cUxPUTRBYXFGX2tRRFdhb0VUREc3WUtXalN0cE02SWpaU2pUbDREOUlMbUFKWmVLcFp1N1piRDZTb0dwNFo5TWgzcE1Jdkt4SE90WjRES0FqRlVnQlZQaWxVNlp3cFBtMHgtWVA3UzVpQzlQMnhqei1MV2xMc1UxS1FhOU91UThDY3M5Z0ow?oc=5) |
| Everyday Health | Pancreatic Cancer Vaccine Shows Promise in Early Trial | 2026-07-16 05:01 | [Source Link](https://news.google.com/rss/articles/CBMipAFBVV95cUxNOUdnVWNDbGZQRTBXdjlrcHVGelR5ZnV1OGdvUnBMOGhMMmphUmw0M25MZnB1cmN6dHRPOWFtVVJuTzFoYWdva3Z1TnNsVzRnLTZucDVuSG5ydG5zYkMybTRpdlVUX1FMYVVVSG04QzF2akNwd3E0bWhURHVkMGh6VVlYam5qNzlkSkZRdUttcjRaTWphbVBlT1BUakpFS3V6eDE3bw?oc=5) |
| Bioengineer.org | Safe vaccine triggers durable immune responses to prevent pancreatic cancer in high-risk people | 2026-07-16 05:01 | [Source Link](https://news.google.com/rss/articles/CBMivAFBVV95cUxPakRuRXBrdlA2bi1FZXQ4WTFPRTFjam5pakR0T281OGViLUFiYVlUNXdhdHlLZDBtVVRaUlNnV1JoNEdjZlY3ZnI1T0F2R2l2RDlVTHMxcDBqeTdNa2ZZSWhDYmNIeDFHSjh6eUczNTZOMmVXNHJ3WFphLXVDNUpHZzhza2g0RmxKdDZSakJDN2xPcVRCSlJkVW5DM08zTXNLcEN6UEZKRFk4ZUFfcGk5RXFNUHNYYjBSSVlfVg?oc=5) |
| Medical Xpress | Experimental pancreatic cancer vaccine elicits durable immune responses in high-risk participants | 2026-07-16 05:01 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxPUVFkcElYYS1WY2R0YzZ5cHBnRWh3YkEwNmtXallENTM5bjdTYmJPcGx5OHY4Q3NNOGk2SXBVYkZXOXFfVUxMR2g0SzRhV2Q2bF9kczBGVkJPYnN0WFc4QnA0NW9oWU9xeG1SWkdrcTV4RUhHVnV1cmd1RGJ0Xy16TTdURkx3SVptbGR5UTVyT21nakRT?oc=5) |
| Johns Hopkins Medicine | Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk | 2026-07-16 05:01 | [Source Link](https://news.google.com/rss/articles/CBMi_AFBVV95cUxPMmkwMTQyQlQyOXcydThJR2p1ZmhlUEdMX2FkbjNkb0k5OU5XVF94bmRmTVZtcG1oc0RGN0o0RmxXUzVhSFA1NWJlQjhlUW1reXlaSWo4QmNCeTdxZzJjU1RXR0xnVmRLRzlDcWhqa3ZiOHo0WnlxVU9aTU5fN3VGSnR4ZUpjSVRObzEzcmJTejJZVWtTSnlFX2dVdWgzcVZ6bUltcUJKV015WVRyTlI2Ri1Ba256dzNyVjN4SXEtY0JjSjNLel85emphUzhrTWNMRk5Nb1pyaklpeWY1Rm5uWTdkU2s2UE10cFNwVHA3bTc1S3NTSFpJeVA3ZnE?oc=5) |
| Oncodaily | Anirban Maitra։ KRAS-Targeted Vaccine Feasibility in High-Risk Individuals for Pancreatic Cancer | 2026-07-16 05:01 | [Source Link](https://news.google.com/rss/articles/CBMiYEFVX3lxTFA5dWh6M1BidkItcC1wcGFKQTRCY1lpODFraGNDUzBUWF9KVmtLeTIwcGs5QVU2YlNkSzItOU9xbHA5amExUXZaa1VqY05QQW1JZUxVdWEzRWRUU0ZmbHk2Qw?oc=5) |
| American Association for Cancer Research (AACR) | From Treatment to Prevention: How Vaccines Are Reshaping the Fight Against Pancreatic Cancer | 2026-07-16 05:01 | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxNNFphSHZiSm9RS1RwZFhpZlRJZk5DQ010d1hGMVJ3NTV6RFRWNkhYREV3UjBFbjE2VFppNHR2MHZwXzRjUjF3VzM4eUhmVHNHZ3Q3Tk9sM0FBVjc4Y2dVWWE2MHJxWUtoUzFzZG5aVF9ySlhfaDhKT3BzMGZ1SkxrUVNaeE9ObUFQSUx6XzVVWmJBVzVhX1lqOVByNzcxcGFyUXo0TVIyLWZqdUxtME42UVg0OXNXazFod3dKaTlqSGRiTVBHWEU0OA?oc=5) |
| American Association for Cancer Research (AACR) | A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses | 2026-07-16 05:01 | [Source Link](https://news.google.com/rss/articles/CBMi_wFBVV95cUxPZThtdHd4RGZzMHh3Xzk5eF8tcC1sYjRxeUhvc091c3EtQ21vc3l6bUw4T2w2MnRHQS05dEQ1c1BzQlJUWUtEeHhpWFljRURtZng4WUo5Q29rQmtfSlJ1ODNKOExjRUlqVEphVTQxV3FwRWFSN2NGQ1VfUVdEV2cxN1pJN0FXUWpnNU5HVFJWc19uTVZLQjBBTmFRam94S3liMEJ1dmNDcWpkQmloYm5Rel81eVFJVDJuellodUk3Z20yOEVsaEhaZ0E1NjhUTlc2UzNoLVJxYzFhUXk1Z3lVYXNhM1hoYWtYVEdfZlh3Rko2bGxjTFBxU042TkgtaTA?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-07-17/a-vaccine-to-prevent-pancreatic-cancer-in-high-risk-individuals-was-safe-and*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*